Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Specimen Handling × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 73 Prostatic Neoplasms 66 Leukemia, Myeloid, Acute 65 Carcinoma, Non-Small-Cell Lung 56 Neoplasm Metastasis 52 Breast Neoplasms 51 Multiple Myeloma 43 Colorectal Neoplasms 37 Myelodysplastic Syndromes 31 Carcinoma, Renal Cell 31 Ovarian Neoplasms 29 Triple Negative Breast Neoplasms 28 Pancreatic Neoplasms 28 Melanoma 27 Leukemia, Lymphocytic, Chronic, B-Cell 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, Large B-Cell, Diffuse 24 Glioblastoma 24 Urinary Bladder Neoplasms 22 Lymphoma 21 Burkitt Lymphoma 21 Fallopian Tube Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 19 Glioma 19 Carcinoma, Hepatocellular 19 Endometrial Neoplasms 17 Oropharyngeal Neoplasms 15 Mouth Neoplasms 15 Lymphoma, Follicular 15 Leukemia, Biphenotypic, Acute 15

Interventions

regorafenib 1 beta-Aminoethyl Isothiourea 1 Trastuzumab 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Self Care 1 Ocoxin 1 Nutrition Assessment 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Motivational Interviewing 1 Leuprolide 1 Lapatinib 1 Goserelin 1 Diet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06635005 2025-10-16

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡